Dr Suzanne Parker

NHMRC Early Career Fellow

UQ Centre for Clinical Research
Faculty of Medicine
suzanne.parker@uq.edu.au
+61 7 334 65040

Overview

Dr Parker's fundamental research interest is the improved healthcare of infants and children through evidence-based drug dosing. Dr Parker is a bioanalyst with 20 years of experience designing methods to measure drugs in biological fluids, positioning her to develop kinder, less-invasive sampling methods that can improve the feasibility of clinical dosing studies. Dr Parker’s research career has furthered these laboratory skills into a translational framework: by applying innovation in microsampling her research will define evidence-based antibiotic dosing regimens.

Research Impacts

To advance her research program, in 2016 Dr Parker established the Clinical Microsampling Group. Her research and experience is cross-disciplinary - based in infectious diseases, pharmacokinetic modelling and bioanalysis

Dr Parker has a series of important publications culminating in the characterization of fosfomycin, an antibiotic vital for the treatment of multi-drug resistant pathogens. This provided crucial evidence for effective dosing of this antibiotic in critically ill patients and advanced change in clinical practice. Dr Parker’s research has also produced world-first evidence essential for the implementation of microsampling in a clinical environment. Dr Parker has developed population pharmacokinetic models for clinical collaborators to describe dosing of drugs in challenging patient groups.

Qualifications

  • Graduate Diploma in Communication, The University of Queensland
  • Doctor of Philosophy, The University of Queensland
  • Bachelor of Applied Science (Applied Chemistry), Qld. UT

Publications

View all Publications

Publications

Journal Article

Conference Publication

  • Addison, R. S., Dickinson, R. G., Eadie, M., Hooper, W. D., Parker-Scott, S. L. and Reith, D. (2000). Aspects of time- and concentration-related of valproate in humans. In: Proceedings of ASCEPT. Annual Scientifc Meeting of ASCEPT, Newcastle, Australia, (121-121). 03-06 Dec, 2000.

  • Addison, R. S., Dickinson, R. G., Hooper, W. D. and Parker-Scott, S. L. (2000). Effect of naproxen co-administration on valproate disposition. In: Drug Metabolism Reviews. DMW/ISSX 2000 Meeting, St Andrews, Scotland, (29-29). 11-16 Jun, 2000.

  • Addison, R. S., Dickinson, R. G., Hooper, W. D. and Parker-Scott, S. L. (2000). Interplay between b-oxidation and glucuronidation of valproate in humans. In: Drug Metabolism Reviews. DMW/ISSX 2000 Meeting, St Andrews, Scotland, (62-62). 11-16 Jun, 2000.

  • Addison, R. S., Dickinson, R. G., Eadie, M., Hooper, W. D. and Parker-Scott, S. L. (2000). The renal handling of valproate and several metabolites in humans. In: Proceedings of ASCEPT. Annual Scientific Meeting of ASCEPT, Newcastle, Australia, (121-121). 03-06 Dec, 2000.

  • Addison, R. S., Dickinson, R. G., Hooper, W. D. and Parker-Scott, S. L. (1999). Effect of Naproxen co-administration on Valproate disposition. In: Abstracts of the Scientific Meeting of ASCEPT. 33rd Annual Scientific Meeting of ASCEPT, Sydney Convention & Exhibition Cen., Darling Harbour, (136-136). 4 - 8 Dec, 1999.

  • Addison, R. S., Dickinson, R. G., Eadie, M. J., Hooper, W. D. and Parker-Scott, S. L. (1999). Steady state dispositions of Valproate and Diflunisal alone and coadministered to healthy volunteers. In: Proceedings of ASCEPT 33rd Annual Scienctific Meeting. ASCEPT, Sydney Convention & Exhibition Cen., Darling Harbour, (146). 4 - 8 Dec, 1999.

Other Outputs